Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Aclidinium Bromide in COPD
NCT01120093Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- May 2010
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of aclidinium in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started May 2010; status: completed.
02
Drugs
aclidinium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01120093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01120093.